Maria Sanchez-Ledesma
Overview
Explore the profile of Maria Sanchez-Ledesma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, Watanabe H, Baron S, Healy J, et al.
Blood Coagul Fibrinolysis
. 2008 Jul;
19(5):401-4.
PMID: 18600089
Argatroban is increasingly used in patients with heparin-induced thrombocytopenia. Although the recommended activated clotting time during percutaneous coronary intervention is 300-450 s, this recommendation is based on the limited data....
12.
Cruz-Gonzalez I, Pabon P, Rodriguez-Barbero A, Martin-Moreiras J, Pericacho M, Sanchez P, et al.
J Cell Mol Med
. 2008 May;
12(3):955-61.
PMID: 18494936
Endoglin is a proliferation-associated and hypoxia-inducible protein expressed in endothelial cells. The levels of soluble circulating endoglin and their prognostic significance in patients with acute myocardial infarction (AMI) are not...
13.
Cruz-Gonzalez I, Cubeddu R, Sanchez-Ledesma M, Cury R, Coggins M, Maree A, et al.
Int J Cardiol
. 2008 Feb;
134(1):e1-3.
PMID: 18272242
Patients with atrial fibrillation are at an increased risk of having a cardioembolic stroke. Most of the thrombi responsible for these ischemic events originate in the left atrial appendage (LAA)....
14.
Cruz-Gonzalez I, Sanchez-Ledesma M, Sanchez P, Jang I
Rev Esp Cardiol
. 2007 Oct;
60(10):1071-82.
PMID: 17953929
Hemorrhage is the most common and best-recognized complication of heparin treatment. However, a potentially more dangerous complication is the development of heparin-induced thrombocytopenia (HIT). All patients exposed to heparin, irrespective...
15.
Cruz-Gonzalez I, Sanchez-Ledesma M, Baron S, Healy J, Watanabe H, Osakabe M, et al.
J Thromb Thrombolysis
. 2007 Jul;
25(2):214-8.
PMID: 17632689
Background: There is limited experience with the use of argatroban in combination with glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitor in acute coronary syndrome (ACS) patients with heparin-induced thrombocytopenia (HIT) undergoing percutaneous coronary...
16.
Cruz-Gonzalez I, Martin-Herrero F, Gonzalez-Santos J, Gutierrez-Diez J, Sanchez-Ledesma M, Maree A
Circulation
. 2007 Jun;
115(25):e643-5.
PMID: 17592084
No abstract available.
17.
Cruz I, Sanchez-Ledesma M, Puerto E, Sanchez-Rodriguez A
Med Clin (Barc)
. 2005 Sep;
125(5):198-9.
PMID: 16153364
No abstract available.